Ondansetron is a 5-hydroxytryptamine receptor antagonist which is known to be a highly effective anti-emetic drug for chemotherapy-associated nausea and vomiting and for postoperative nausea. We report here a case where ondansetron was used in severe hyperemesis gravidarum to avoid parenteral nutrition. The drug was used intermittently in every trimester with no apparent adverse effects on mother or infant.
No takes yet. Share an insight, caveat, or question.
Tincello et al. (1996) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: